Effect of the antiobesity agent sibutramine in obese-diabetic ob/ob mice

International Journal of Obesity

Volumn 22, Issue 7, 1998, Pages 619-623

  Day, C ^a   Bailey, C J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Body weight; Fatty acids; Glucose; Insulin resistance; Obese diabetic ob ob mice; Sibutramine

Indexed keywords

ANTIOBESITY AGENT; FATTY ACID; GLUCOSE; INSULIN; NORADRENALIN; SEROTONIN; SIBUTRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; FATTY ACID BLOOD LEVEL; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HYPERINSULINEMIA; INSULIN RESISTANCE; MOUSE; NONHUMAN; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TIME; WEIGHT GAIN;

ANIMALIA;

EID: 0031837935     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800636     Document Type: Article

References (24)

1. Buckett WR, Thomas PC, Luscombe GP. The pharmacology of sibutramine hydrochloride (BTRS 54524), a new antidepressant which induces rapid noradrenergic down-regulation. Prog Neuropsychopharmacol Bio Psychiatry 1988; 12: 575-584.
2. Weintraub M, Rubio A, Goli A, Byrne L, Scheinbaum ML. Sibutramine in weight control: a dose-ranging, efficacy study. Clin Pharmacol Ther 1991; 50: 330-337.
3. Fantino M, Martel P, Souquet AM, Wieteska L, Brondel L, Courcier S. Decrease of food intake and weight loss induced by sibutramine in the rat. Obes Res 1995; 3 (suppl 4): 628S.
4. Halford JCG, Heal DJ, Blundell JE. Effects in the rat of sibutramine on food intake and the behavioural satiety sequence. Br J Pharmacol 1995; 114: 387P
5. Connoley IP, Heal DJ, Stock MJ. A study in rats of the effects of sibutramine on food intake and thermogenesis. Br J Pharmacol 1995; 114: 388P.
6. Vargas R, McMahon FG, Jain AK. Effects of sibutramine versus placebo in NIDDM. Clin Pharmacol Ther 1994; 53: 188.
7. Griffiths J, Brynes AE, Frost G, Bloom SR, Finer N, Jones SP, Romance FM. Sibutramine in the treatment of overweight non-insulin dependent diabetics. Int J Obes 1995; 19(suppl 2): 41.
8. Bailey CJ, Flatt PR. Animal syndromes of non-insulin-dependent diabetes mellitus. In: Pickup JC, Williams G (eds). Textbook of Diabetes (2nd edn). Blackwell Science: Oxford, 1997, pp23.1-23.25.
9. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
10. Flatt PR, Bailey CJ. Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice. Diabetologia 1981; 20: 573-577.
11. Bailey CJ, Flatt PR, Atkins TW. Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob mice. Int J Obes 1982; 6: 11-21.
12. Bailey CJ, Flatt PR, Ewan C. Anorectic effect of metformin in lean and genetically obese hyperglycaemic (ob/ob) mice. Arch Int Pharmacodyn 1986; 282: 233-239.
13. Stevens JF. Determination of glucose by an automatic analyser. Clin Chim Acta 1971; 32: 199-201.
14. Flatt PR, Bailey CJ. Development of glucose intolerance and impaired plasma insulin response to glucose in obese hyperglycaemic (ob/ob) mice. Horm Metab Res 1981; 13: 556-560.
15. Bailey CJ, Flatt PR. Anorectic effect of fenfluramine. cholecystokinin and neurotensin in genetically obese (ob/ob) mice. Comp Biochem Physiol 1986; 84A: 451-454.
16. Flatt PR, Bailey CJ. Glucose and insulin response to conditioned feeding in lean and genetically obese hyperglycemic (ob/ob) mice. Metabolism 1983; 32: 504-509.
17. Jackson HC, Bearham MC, Hutchins LJ, Mazurkiewicz SE, Needham AM, Heal DJ. Investiation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenuline reuptake inhibitor, sibutramine, in the rat. Br J Pharmacol 1997; 121: 1613-1618.
18. Williams G, Wilding J. The central nervous system and diabetes mellitus. In: Pickup JC, Williams G (eds). Textbook of Diabetes (2nd edn). Blackwell Science: Oxford, 1997, pp 65.1-65.30.
19. Wang Q, Bing C, Al-Barazanji K, Mossakowaska DE. Wang X-M, McBay DL, Neville WA, Taddayon M, Pickavance L, Dryden S, Thomas MEA, Mettale MT, Gloyer IS, Wilson S, Buckingham R, Arch JRS, Trayhum P, Williams G. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes 1997; 46: 335-341.
20. Connoley IP, Frost I, Heal DJ, Stock MJ. Role of β-adrenoceptors in mediating the thermogenic effects of sibutramine. Br J Pharmacol 1996; 116: 170.
21. Griffiths J, Bloom SR, Finer N, Jones SP, Romance FM. Body composition changes following weight loss induced by sibutramine. Int J Obes 1995; 19 (Suppl 2): 144.
22. Jung RT. Obesity and nutritional factors in the pathogenesis of non-insulin-dependent diabetes mellitus. In: Pickup JC, Williams G (eds). Textbook of Diabetes (2nd edn) Blackwell Science: Oxford, 1991, pp 19.1-19.23.
23. Stallone DD, Levitsky DA. Chronic fenfluramine treatment: effects on body weight, food intake and energy expenditure. Int J Obes 1994; 18: 679-685.
24. Bailey CJ, Thomburn CC, Flatt PR. Effects of ephedrine and atenolol on the development of obesity and diabetes in ob/ob mice. Gen Pharmac 1986; 17: 243-246.